Literature DB >> 22966298

Signet ring cell-type adenocarcinoma arising in a mature teratoma of the testis.

Hong Koo Ha1, Wan Lee, Sang Don Lee, Jeong Zoo Lee, Moon Kee Chung.   

Abstract

A 48-year-old male who presented with an enlarged right scrotum was diagnosed with malignant transformation of testicular teratoma. Physical examination revealed a right scrotal mass of hard consistency with no inguinal lymphadenopathy. Since prepuberty, his right testis had been larger than the left one, with no pain or tenderness. Computed tomography and bone scan revealed retroperitoneal lymphadenopathy and multiple bone metastases. Right orchiectomy was performed immediately, and a pathological examination revealed a mature teratoma associated with adenocarcinoma, showing signet ring cell differentiation. Cisplatin-based combination chemotherapy was administered; however, the metastatic lesions progressed, and the patient succumbed to the disease after 15 months. Only a few cases of primary malignant transformation of teratoma in the testis have been reported, and this is the first case report of primary malignant transformation of teratoma in the testis with signet ring cell-type differentiation.

Entities:  

Year:  2010        PMID: 22966298      PMCID: PMC3436447          DOI: 10.3892/ol_00000053

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  13 in total

Review 1.  Adenocarcinoma arising from respiratory ciliated epithelium in mature ovarian cystic teratoma.

Authors:  T Sumi; O Ishiko; K Maeda; T Haba; K Wakasa; S Ogita
Journal:  Arch Gynecol Obstet       Date:  2002-12       Impact factor: 2.344

2.  Primary signet-ring stromal tumor of the testis.

Authors:  Michal Michal; Ondrej Hes; Dmitry V Kazakov
Journal:  Virchows Arch       Date:  2005-05-21       Impact factor: 4.064

3.  Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases.

Authors:  C V Comiter; A S Kibel; J P Richie; M R Nucci; A A Renshaw
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

4.  Prepubertal testis tumors: actual prevalence rate of histological types.

Authors:  Hans G Pohl; Aseem R Shukla; Peter D Metcalf; Bartley G Cilento; Alan B Retik; Darius J Bagli; Dale S Huff; H Gil Rushton
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

5.  Chemotherapy in patients with teratoma with malignant transformation.

Authors:  Omar El Mesbahi; Marie-Josée Terrier-Lacombe; Christine Rebischung; Christine Theodore; Daniel Vanel; Karim Fizazi
Journal:  Eur Urol       Date:  2006-10-25       Impact factor: 20.096

6.  Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution.

Authors:  Jeong-Yeol Park; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2008-09-26       Impact factor: 2.435

7.  Experience with testis sparing surgery for testicular teratoma.

Authors:  Aseem R Shukla; Christopher Woodard; Michael C Carr; Dale S Huff; Douglas A Canning; Stephen A Zderic; Thomas F Kolon; Howard M Snyder
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

8.  Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.

Authors:  Seog-Yun Park; Baek-Hee Kim; Jung-Ho Kim; Sun Lee; Gyeong Hoon Kang
Journal:  Arch Pathol Lab Med       Date:  2007-10       Impact factor: 5.534

9.  Signet-ring stromal tumor of the testis: a case report and literature review.

Authors:  Chen Yun Kuo; Mei Chin Wen; John Wang; Yee Jee Jan
Journal:  Hum Pathol       Date:  2008-10-05       Impact factor: 3.466

10.  Adenocarcinoma originating from a mature teratoma of the testis.

Authors:  Resit Dogan Koseoglu; Bekir Suha Parlaktas; Nurper Onuk Filiz; Fikret Erdemir; Nihat Uluocak; Ozden Tulunay
Journal:  Kaohsiung J Med Sci       Date:  2007-05       Impact factor: 2.744

View more
  1 in total

Review 1.  Testicular teratomas: a growing problem?

Authors:  Wojciech Michalski; Joanna Jonska-Gmyrek; Grazyna Poniatowska; Jakub Kucharz; Pawel Stelmasiak; Karol Nietupski; Malgorzata Sadowska; Tomasz Demkow; Pawel Wiechno
Journal:  Med Oncol       Date:  2018-10-26       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.